CervoMed Inc.
CRVO
$2.73
-$0.20-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 8.70K | 322.60K | 1.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 8.70K | 322.60K | 1.76M |
| Cost of Revenue | 137.20K | 5.14M | 5.83M | 6.04M | 121.20K |
| Gross Profit | -137.20K | -5.14M | -5.82M | -5.72M | 1.64M |
| SG&A Expenses | 2.36M | 2.98M | 2.51M | 2.33M | 3.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.68M | 8.11M | 8.34M | 8.37M | 8.37M |
| Operating Income | -6.68M | -8.11M | -8.33M | -8.04M | -6.62M |
| Income Before Tax | -6.57M | -7.96M | -8.09M | -7.73M | -6.26M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.57M | -7.96M | -8.09M | -7.73M | -6.26M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.57M | -7.96M | -8.09M | -7.73M | -6.26M |
| EBIT | -6.68M | -8.11M | -8.33M | -8.04M | -6.62M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.64 | -0.86 | -0.87 | -0.84 | -0.70 |
| Normalized Basic EPS | -0.40 | -0.54 | -0.55 | -0.52 | -0.44 |
| EPS Diluted | -0.64 | -0.86 | -0.87 | -0.84 | -0.70 |
| Normalized Diluted EPS | -0.40 | -0.54 | -0.55 | -0.52 | -0.44 |
| Average Basic Shares Outstanding | 10.24M | 9.26M | 9.26M | 9.25M | 8.95M |
| Average Diluted Shares Outstanding | 10.24M | 9.26M | 9.26M | 9.25M | 8.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |